Analyst Ratings January 29, 2026

UBS Moves Warrior Met Coal to Buy as Blue Creek Progress Spurs Upside Case

Analyst cites Blue Creek ramp and tight met coal market; price target raised to $108 amid recent earnings beat and federal lease awards

By Avery Klein HCC
UBS Moves Warrior Met Coal to Buy as Blue Creek Progress Spurs Upside Case
HCC

UBS upgraded Warrior Met Coal (HCC) from Neutral to Buy and lifted its price target to $108 from $100, citing an inflection driven by the Blue Creek project ramp, shorter-term market tightness in metallurgical coal and stronger operational performance. The firm expects double-digit returns in the back half of the year and flagged additional upside from potential volume additions and higher prices.

Key Points

  • UBS upgraded Warrior Met Coal from Neutral to Buy and raised its price target to $108 from $100, implying upside from the $90.09 trading level.
  • UBS expects double-digit returns from Warrior Met beginning in H2 as Blue Creek ramps, and sees near-term support from a tight metallurgical coal market due to weather disruptions in Queensland, Australia.
  • Recent positive developments include a Q3 2025 earnings beat, federal coal leases covering ~14,000 acres with estimated 53.2 million short tons recoverable, and Moody’s shifting the outlook to positive.

UBS has upgraded Warrior Met Coal (NYSE:HCC) from Neutral to Buy and increased its price target to $108.00 from $100.00. The new target implies upside from the stock’s recent trading level of $90.09. The share price has nonetheless experienced pressure over the last week, dropping 8.38% according to InvestingPro data, even as the name has delivered a strong 68.51% gain over the past 12 months and trades at a stretched P/E of 133.68.

In a note accompanying the move, UBS analyst George Eadie said Warrior Met appears to be at an "inflection point where returns and margins look compelling." The firm expects the company to begin delivering double-digit returns in the second half of the year as production from the Blue Creek metallurgical coal development ramps up. UBS projects saleable tons from Blue Creek in the first half of 2026 and anticipates that Warrior Met will outline a returns policy in the second half of the year, a step the bank sees as a potential catalyst for further share-price appreciation ahead of incremental growth and returns considerations for 2027 and beyond.

UBS also pointed to near-term tightness in the metallurgical coal market as a driver of upside, attributing the constrained supply environment in part to weather-related disruptions in Queensland, Australia. The firm said these conditions should provide support for stronger prices in the short term and that this market backdrop, combined with Warrior Met’s execution, could push results ahead of consensus in 2026-2027.

While UBS expects the company to issue conservative guidance for 2026 in the coming weeks, the bank highlighted additional potential sources of upside that the market may not yet be valuing, including the possibility of a second longwall at Blue Creek and higher-than-expected coal prices.


Recent operating and corporate developments

  • Warrior Met reported third-quarter 2025 results that outperformed analyst expectations, with earnings per share of $0.70 versus a forecasted -$0.30, and revenue of $328.5 million compared with an anticipated $305.4 million.
  • The company secured federal coal leases covering roughly 14,000 acres in Alabama, with an estimated 53.2 million short tons of recoverable coal reserves. Those leases were awarded through the Bureau of Land Management’s competitive Lease By Application process.

Separately, Moody’s Ratings moved Warrior Met Coal’s credit outlook to positive from stable, citing meaningful progress on the Blue Creek mine development. In another note included in recent coverage, UBS is reported to have raised a price target to $80 from $75 while maintaining a Neutral rating, citing improved cash cost forecasts and strong operational results. These multiple signals from ratings and research desks illustrate a period of notable activity and reassessment around the company’s trajectory.


What to watch

Key milestones to monitor include the timing and volume of saleable tons from Blue Creek in H1 2026, the company’s 2026 guidance when released, and the formal return-of-capital policy expected in H2. Outcomes on those fronts, coupled with metallurgical coal price moves, will inform whether UBS’s double-digit returns forecast and the elevated price target prove prescient.

Investors should also note the stock’s recent volatility. Despite strong year-over-year performance, the high trailing P/E signals elevated investor expectations that will need to be met by operational delivery and favorable market dynamics.

Risks

  • Company guidance for 2026 may be conservative as UBS expects; conservative guidance could limit near-term share movement - impacts equity investors and the materials sector.
  • Commodity price risk: metallurgical coal prices could underperform UBS’s assumptions, reducing potential upside to 2026-2027 consensus estimates - impacts miners, steel producers, and commodity markets.
  • Execution risk at Blue Creek, including timing and throughput of saleable tons and decisions on a second longwall, could delay expected returns and policy announcements - impacts Warrior Met operational outlook and investor returns.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026